Gonadal function and fertility after Hodgkin lymphoma treatment with nivolumab-AVD in the phase 2 GHSG NIVAHL trial.
Saved in:
| Title: | Gonadal function and fertility after Hodgkin lymphoma treatment with nivolumab-AVD in the phase 2 GHSG NIVAHL trial. |
|---|---|
| Authors: | Robertz AS; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, and German Hodgkin Study Group, Cologne, Germany., Bühnen I; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, and German Hodgkin Study Group, Cologne, Germany., Meissner J; Medicine V, University of Heidelberg, Heidelberg, Germany., Trautmann-Grill K; Department of Medicine I, Faculty of Medicine and University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany., Herhaus P; Clinic and Policlinic for Internal Medicine III, Klinikum Rechts der Isar, School of Medicine, Technical University Munich, Munich, Germany., Halbsguth TV; Division of Hematology/Oncology, Department of Medicine II, Goethe University Hospital Frankfurt, Frankfurt, Germany., Schaub V; Department of Internal Medicine II, University Hospital Tübingen, Tübingen, Germany., Kerkhoff A; Medizinische Klinik A, University Hospital Münster, Münster, Germany., Mathas S; Division of Hematology, Oncology, and Tumor Immunology, Charité Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, Berlin, Germany., Bormann M; Medical Department I, Klinikum Bremen-Mitte, Bremen, Germany., Dickhut A; Tumorklinik, Klinikum Fulda, Fulda, Germany., Jaworek CP; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, and German Hodgkin Study Group, Cologne, Germany., Fuchs M; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, and German Hodgkin Study Group, Cologne, Germany., Kobe C; Department of Nuclear Medicine and German Hodgkin Study Group, University Hospital of Cologne, Cologne, Germany., Baues C; Department of Radiation Oncology and German Hodgkin Study Group, Hospital Bochum, Bochum, Germany., Borchmann P; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, and German Hodgkin Study Group, Cologne, Germany., von Tresckow B; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, and German Hodgkin Study Group, Cologne, Germany.; Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer Consortium (Partner Site Essen), University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Behringer K; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, and German Hodgkin Study Group, Cologne, Germany., Bröckelmann PJ; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, and German Hodgkin Study Group, Cologne, Germany. |
| Source: | Blood [Blood] 2026 Jun 18; Vol. 147 (25), pp. 3118-3121. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41926569 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Gonadal function and fertility after Hodgkin lymphoma treatment with nivolumab-AVD in the phase 2 GHSG NIVAHL trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Robertz+AS%22">Robertz AS</searchLink>; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, and German Hodgkin Study Group, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Bühnen+I%22">Bühnen I</searchLink>; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, and German Hodgkin Study Group, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Meissner+J%22">Meissner J</searchLink>; Medicine V, University of Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Trautmann-Grill+K%22">Trautmann-Grill K</searchLink>; Department of Medicine I, Faculty of Medicine and University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Herhaus+P%22">Herhaus P</searchLink>; Clinic and Policlinic for Internal Medicine III, Klinikum Rechts der Isar, School of Medicine, Technical University Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Halbsguth+TV%22">Halbsguth TV</searchLink>; Division of Hematology/Oncology, Department of Medicine II, Goethe University Hospital Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Schaub+V%22">Schaub V</searchLink>; Department of Internal Medicine II, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Kerkhoff+A%22">Kerkhoff A</searchLink>; Medizinische Klinik A, University Hospital Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Mathas+S%22">Mathas S</searchLink>; Division of Hematology, Oncology, and Tumor Immunology, Charité Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Bormann+M%22">Bormann M</searchLink>; Medical Department I, Klinikum Bremen-Mitte, Bremen, Germany.<br /><searchLink fieldCode="AU" term="%22Dickhut+A%22">Dickhut A</searchLink>; Tumorklinik, Klinikum Fulda, Fulda, Germany.<br /><searchLink fieldCode="AU" term="%22Jaworek+CP%22">Jaworek CP</searchLink>; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, and German Hodgkin Study Group, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Fuchs+M%22">Fuchs M</searchLink>; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, and German Hodgkin Study Group, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Kobe+C%22">Kobe C</searchLink>; Department of Nuclear Medicine and German Hodgkin Study Group, University Hospital of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Baues+C%22">Baues C</searchLink>; Department of Radiation Oncology and German Hodgkin Study Group, Hospital Bochum, Bochum, Germany.<br /><searchLink fieldCode="AU" term="%22Borchmann+P%22">Borchmann P</searchLink>; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, and German Hodgkin Study Group, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22von+Tresckow+B%22">von Tresckow B</searchLink>; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, and German Hodgkin Study Group, Cologne, Germany.; Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer Consortium (Partner Site Essen), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Behringer+K%22">Behringer K</searchLink>; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, and German Hodgkin Study Group, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Bröckelmann+PJ%22">Bröckelmann PJ</searchLink>; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, and German Hodgkin Study Group, Cologne, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2026 Jun 18; Vol. 147 (25), pp. 3118-3121. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41926569 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/blood.2025031809 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3118 Titles: – TitleFull: Gonadal function and fertility after Hodgkin lymphoma treatment with nivolumab-AVD in the phase 2 GHSG NIVAHL trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Robertz AS – PersonEntity: Name: NameFull: Bühnen I – PersonEntity: Name: NameFull: Meissner J – PersonEntity: Name: NameFull: Trautmann-Grill K – PersonEntity: Name: NameFull: Herhaus P – PersonEntity: Name: NameFull: Halbsguth TV – PersonEntity: Name: NameFull: Schaub V – PersonEntity: Name: NameFull: Kerkhoff A – PersonEntity: Name: NameFull: Mathas S – PersonEntity: Name: NameFull: Bormann M – PersonEntity: Name: NameFull: Dickhut A – PersonEntity: Name: NameFull: Jaworek CP – PersonEntity: Name: NameFull: Fuchs M – PersonEntity: Name: NameFull: Kobe C – PersonEntity: Name: NameFull: Baues C – PersonEntity: Name: NameFull: Borchmann P – PersonEntity: Name: NameFull: von Tresckow B – PersonEntity: Name: NameFull: Behringer K – PersonEntity: Name: NameFull: Bröckelmann PJ IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 06 Text: 2026 Jun 18 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1528-0020 Numbering: – Type: volume Value: 147 – Type: issue Value: 25 Titles: – TitleFull: Blood Type: main |
| ResultId | 1 |